USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11248
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPavlovschi, Ecaterina
dc.contributor.authorBorovic, Djina
dc.contributor.authorTurcanu, Irina
dc.contributor.authorBilba, Rodica
dc.date.accessioned2020-07-11T18:47:19Z
dc.date.available2020-07-11T18:47:19Z
dc.date.issued2016
dc.identifier.citationPAVLOVSCHI, Ecaterina, BOROVIC, Djina, TURCANU, Irina, BILBA, Rodica. Facts about stargardt disease: advances and obstacles. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, pp. 203-204.en_US
dc.identifier.isbn978-9975-3028-3-8.
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11248
dc.descriptionDepartment of Ophthalmology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016en_US
dc.description.abstractIntroduction: Stargardt disease is the most common juvenile macular dystrophy and hereditary frequent cause of central visual dysfunction in young patients. This disease, whose prevalence is 1:8000, according to other sources 1:10000, was first described in 1909, by Stargardt. According to recent studies, Stargardt disease was the cause of low vision at 13.94% people, aged under 16. Stargardt's disease can occur in one of every 20,000 children, aged equal or greater than 6 years and is usually diagnosed before the age of 20 years. Materials and methods: The purpose of this article was to highlight the general aspects of Stargardt’s disease and also to present a clinical case of a boy aged 6, who came in 2013 at the Medical Center, with the following complaints: decreased in both eyes (OU) of the visual acuity (VA), detected in a prophylactic control. Results: Presentation, clinical features and progression of Stargardt disease varies greatly from patient to patient. From complaints, appears a difficulty in recognizing faces, reading, writing, distinguishing colors and other work that is done nearby, so that the affected person can see objects only from the "corner of his eye" (peripheral vision or sight "side"). Children can be misdiagnosed for a psychological loss of vision, because macula initially appears normal. Over time, characteristic changes occur in the retina that help facilitate the diagnosis. Conclusion: Being present in a marked phenotypic variability, the impact of this disease on visual function is highly variable. It is known that VA declines most often to a level of 20/200 or worse, but usually stabilizes after reaching this level. Although some patients maintain a good VA over several years, others may experience a precipitated loss of VA. A comprehensive and interdisciplinary approach for the vision rehabilitation, can help most patients learn to use the remaining visual capacity to a maximum.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectStargardt diseaseen_US
dc.subjectmanifestationsen_US
dc.subjecttreatmenten_US
dc.subjectrehabilitationen_US
dc.subject.ddc61:378.661(478-25)(082) M 54en_US
dc.titleFacts about stargardt disease: advances and obstaclesen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2016

Files in This Item:
File Description SizeFormat 
Facts_about_stargardt_disease_advances_and_obstacles.pdf277.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback